← Back to Clinical Trials
Recruiting NCT07491549

NCT07491549 The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07491549
Status Recruiting
Phase
Sponsor University of Tartu
Condition Chronic Pain
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2026-04-01
Primary Completion 2030-05-31

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
pain education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2026-04-01 with a primary completion date of 2030-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if pain knowledge group intervention among chronic pain patients would influence their level of physical activity, pain intensity, depression, kinesiophobia and central sensitization. The main question it aims to answer is: Primary hypothesis: pain education will decrease participants' depression and pain intensity and increase their physical activity. There is no comparison group. Participants will participate in a 6-week pain knowledge intervention where they will be learning about sleep, stress models, physical activity benefits, pain neurobiology, mindfulness, pain medication.

Eligibility Criteria

Inclusion Criteria: * Pain lasting longer than 3 months, * Consequences resulting from long-term pain (such as decreased physical activity, sleep disturbances, fatigue, low mood, etc.) Exclusion Criteria: * Surgery that occurred less than 3 months prior * Fracture or limb trauma that occurred less than 3 months prior

Contact & Investigator

Central Contact

Hanna Kalajas-Tilga, PhD

✉ hanna.kalajas-tilga@ut.ee

📞 +372 5816 1041

Frequently Asked Questions

Who can join the NCT07491549 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, up to 65 Years, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07491549 currently recruiting?

Yes, NCT07491549 is actively recruiting participants. Contact the research team at hanna.kalajas-tilga@ut.ee for enrollment information.

Where is the NCT07491549 trial being conducted?

This trial is being conducted at Tartu, Estonia.

Who is sponsoring the NCT07491549 clinical trial?

NCT07491549 is sponsored by University of Tartu. The trial plans to enroll 50 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology